Managing Dyspnea in Hospice: A Symptom-Directed Approach to Breathlessness

Recognizing and Assessing Dyspnea

 
Dyspnea is a symptom, not a diagnosis. When a patient can communicate, their description of breathing discomfort is the most useful measure of symptom severity.

Helpful questions include:

When a patient cannot communicate because of dementia, delirium, neurologic decline, or decreased consciousness, the hospice team can look for signs that may indicate respiratory distress, including:

Restlessness or agitation 

Rapid or visibly labored breathing 

Accessory-muscle use 

 

Nasal flaring or grunting

 

A fearful facial expression 

Difficulty settling despite repositioning or reassurance 

These signs can help the team recognize distress when self-report is not possible.

A note about noisy breathing: Near the end of life, respiratory secretions can make breathing sound wet or noisy without necessarily meaning the patient is experiencing dyspnea. The hospice team should assess the patient's comfort rather than assume that noisy breathing itself indicates distress.

A Practical Hospice Dyspnea Approach

When a hospice patient develops or reports worsening shortness of breath, the team can consider:

1. Assess the distress
Determine what the patient is experiencing and look for observable signs when communication is limited.

2. Consider potential contributors
Think about bronchospasm, fluid overload, infection, pleural effusion, airway inflammation, retained secretions, anxiety, or progression of the underlying illness.

3. Start immediate comfort measures
Use positioning, airflow from a fan, a calm environment, reduced stimulation, breathing techniques when appropriate, and prescribed PRN medications.

4. Consider medications and oxygen based on the clinical situation
For persistent or distressing dyspnea, opioids may provide meaningful relief. Oxygen may be appropriate when symptomatic hypoxemia is present or when the patient experiences clear comfort from it.

5. Reassess as the patient's condition changes
The medication, route, frequency, and overall respiratory regimen may need to change as functional ability declines.

What Can Caregivers Do During an Episode of Breathlessness?

Non-pharmacologic measures should be part of every hospice dyspnea plan. They may provide meaningful relief on their own and can complement medication when symptoms are more severe.

During an episode of shortness of breath, caregivers can:

A calm caregiver presence can also help because breathlessness and fear can reinforce one another. A fan directed toward the face is a particularly simple, low-burden intervention that may provide rapid relief for some patients.

Should Potential Contributors Be Evaluated?

Shortness of breath can have several contributors, some of which may be treatable. The hospice team considers the patient's symptoms, overall condition, goals of care, and the potential benefit and burden of addressing those contributors.

Potential contributors include:

When an underlying contributor can be addressed in a way that is likely to improve comfort, the hospice team may incorporate that treatment into the patient's plan of care.

The goal is to identify opportunities to improve comfort while avoiding interventions that add burden without meaningful benefit.

Opioids for Air Hunger

For persistent or distressing dyspnea, systemic opioids are an important hospice treatment option. Their role in this setting is not limited to pain relief. Opioids can help ease the central experience of breathlessness and air hunger, making breathing feel more comfortable.

They may be used alongside non-pharmacologic measures and treatment of appropriate contributors. Treatment should be individualized based on prior opioid exposure, clinical status, organ function, route of administration, symptom severity, and goals of care.

Key principles include:

• Individualize the starting dose rather than using a one-size-fits-all approach.
• Titrate according to symptom relief and tolerability.
• Use the least burdensome route that remains reliable.
• Consider scheduled therapy when dyspnea is frequent or predictable.
• Provide appropriate bowel-regimen support when opioids are used regularly.
• Reassess both benefit and adverse effects.

The goal is relief of respiratory distress—not sedation for its own sake.

Importantly, opioids do not need to be reserved only for the final hours of life. When breathlessness remains persistent or distressing despite appropriate comfort measures, they can be an appropriate part of symptom-directed hospice care.

When Anxiety or Panic Makes Dyspnea Worse

Breathlessness can trigger fear, and fear can intensify the experience of not being able to breathe comfortably. This cycle can escalate quickly, particularly when patients feel frightened or unable to catch their breath.

Benzodiazepines such as lorazepam may have a role when anxiety or panic is contributing significantly to respiratory distress. They are generally considered an adjunct rather than the primary treatment for air hunger itself.

Hospice clinicians should consider the patient's current medications, level of alertness, sedation and delirium risk, history of anxiety, and response to treatment when deciding whether a benzodiazepine is appropriate.

Oxygen for Dyspnea in Hospice

Oxygen may be appropriate when a patient has symptomatic hypoxemia or experiences meaningful comfort from oxygen therapy.

However, oxygen is not automatically the best treatment for shortness of breath. For patients without symptomatic hypoxemia, oxygen may not provide meaningful additional relief, and the equipment itself can create burden.

For patients already using oxygen, the hospice team can reassess whether it continues to provide meaningful comfort and whether the equipment remains practical for the patient and family.

The goal is symptom relief, with oxygen therapy guided by the patient's symptoms, clinical condition, and response to treatment—not by a target oxygen saturation alone.

When the Route Becomes Part of the Treatment Plan

Respiratory medications can remain useful in hospice, but the way they are delivered may need to change as strength, cognition, coordination, swallowing ability, and functional status decline.

A metered-dose inhaler requires coordination between device activation and inhalation. A dry-powder inhaler requires sufficient inspiratory effort to deliver medication effectively. Frailty, tremor, arthritis, weakness, cognitive decline, delirium, and reduced inspiratory flow can make these devices increasingly difficult to use.

Hospice teams can periodically reassess:

Continue or reassess for benefit

• Patient can use the device effectively

• Medication provides clear symptom relief

• Patient prefers the treatment

• Treatment remains consistent with comfort-focused goals

• Benefit remains observable

Consider changing or discontinuing

• Inspiratory flow or coordination is inadequate

• Weakness, tremor, arthritis, or cognitive decline interferes with administration

• Caregiver administration becomes difficult or burdensome

• Treatment burden exceeds likely benefit

• Benefit is unclear despite appropriate use

A caregiver-administered nebulizer may be easier for some patients, but it is not automatically a better option. Nebulized therapy still requires equipment, medication access, administration time, and caregiver involvement.

The same principle applies to bronchodilators and corticosteroids. These therapies may continue to provide meaningful benefit when bronchospasm, wheezing, airway inflammation, or another responsive condition contributes to dyspnea. As the patient declines, the team may identify opportunities to:

• Simplify complex respiratory regimens
• Remove duplicate or low-benefit therapies
• Transition to a more feasible delivery method
• Reassess maintenance therapies with unclear comfort benefit
• Reduce treatment burden when expected benefit is limited

The right medication is only useful if the patient can receive it reliably—and the right route is the one that provides meaningful comfort without unnecessary burden.

This becomes particularly important in home hospice, where medication access, formulation, administration technique, and caregiver capability can directly affect whether a symptom-management plan works.

How Dyspnea Management Changes as Hospice Patients Decline

The most appropriate respiratory plan may change significantly over the course of hospice care.

Earlier in hospice

• Patient may self-administer medications

• Oral and inhaled routes may work well

• Complex respiratory regimens may be manageable

• PRN treatment may be sufficient

 

As illness progresses

• Caregiver may need to administer them

• Alternative routes may become necessary

• Simplification may become more appropriate

• Scheduled therapy may become appropriate

This is why dyspnea management should be viewed as an ongoing process rather than a one-time medication decision.

Common Pitfalls in Hospice Dyspnea Management

Certain approaches can unintentionally add burden or miss an opportunity for better symptom relief.

• Focusing on oxygen saturation instead of symptoms. The pulse oximeter provides information but does not tell the whole story of the patient's breathing experience.
• Assuming oxygen is always the answer. Oxygen should have a comfort rationale rather than being used automatically for every episode of dyspnea.
• Continuing an inhaler when effective use has become difficult. A prescribed inhaler is not necessarily an effective inhaler if the patient can no longer use it properly.
• Addressing anxiety without also considering air hunger. Anxiety can amplify dyspnea, but it should not automatically replace treatment directed at the breathing discomfort itself.
• Adding medication without reassessing the overall regimen. A medication review may identify duplication or treatment burden before another therapy is added.
• Waiting until swallowing becomes difficult to consider route changes. Anticipating changes in administration can help prevent avoidable delays in symptom relief.

How Hospice Pharmacists Support Dyspnea Management

Dyspnea management can change quickly as a patient's condition and ability to administer medications change.

Hospice pharmacists can support the interdisciplinary team by:

Effective hospice dyspnea management is therefore not simply about selecting a medication. It requires ongoing assessment, appropriate routes and formulations, regimen simplification, and timely access as the patient's condition changes.